CNW Headlines
Home » Archives for July 2024 » Page 5

Month: July 2024

FridayJul 05, 2024 4:20 pm

420 with CNW — Marijuana Operators in Pennsylvania Complain About Software Mandated by Regulators

Pennsylvania’s medical cannabis market generated more than $1.3 billion in sales in 2023, despite numerous issues and outages with the state’s mandated track-and-trace software. Operators claim these problems could be avoided if the software provided by MJ Freeway functioned correctly. Although MJ Freeway recently merged with BioTrack to form Alleaves, it remains the sole provider under a contract established in 2017. Industry operators and a few legislators have voiced frustrations regarding MJ Freeway’s lack of a two-way Application Programming Interface (API) with other approved software used for sales and inventory management. This means businesses must manually input data, such as…

Continue Reading

FridayJul 05, 2024 10:00 am

US Transportation Secretary Says Marijuana Reclassification Won’t Change Trucker Drug Testing

Secretary of Transportation Pete Buttigieg recently announced that cannabis’ reclassification wouldn’t impact drug testing policies for truckers. While speaking at a congressional hearing this past week, he explained that this was primarily because the U.S. Transportation Department listed cannabis as a substance to screen for. Buttigieg had been responding to a question tabled during a hearing of the House Committee on Transportation and Infrastructure asked by Representative Rick Crawford. Crawford had brought up concerns about the extensive public safety and health consequences of cannabis rescheduling on the country’s highway system and those who used it, such as members of the…

Continue Reading

WednesdayJul 03, 2024 10:00 am

IRS Tells Cannabis Firms That 280E Tax Deductions Are Unavailable Till CSA Reclassification Complete

In a recent press release, the Internal Revenue Service advised that cannabis companies refrain from taking federal tax deductions for business expenses. While these deductions are provided for other businesses under section 280E, cannabis businesses aren’t allowed to mainly because the drug is still a controlled substance. Section 280E doesn’t allow credits or deductions for any amount incurred or paid in conducting any business or trade that includes trafficking a Schedule 1 or 2 substance. This applies to businesses that sell cannabis, even if they operate in legal states. Currently, cannabis is classified as a Schedule 1 substance under the…

Continue Reading

TuesdayJul 02, 2024 4:20 pm

420 with CNW — Study Finds Older Medical Marijuana Patients Experience Marked Health, Well-Being Improvements

A recent study has revealed that medical cannabis can offer numerous therapeutic benefits for older adults, positively impacting their mood, sleep, health and well-being. The study observed significant reductions in both pain interference and severity in older adults who use cannabis to manage chronic pain. Published in the “Drugs and Aging Journal,” the study addresses the limited high-quality studies on marijuana use among older adults. Typically, clinical trials exclude participants older than 65 years of age, even as this demographic increasingly turns to medical cannabis for relief. The research, which was carried out by a group from Drug Science and…

Continue Reading

MondayJul 01, 2024 4:20 pm

420 with CNW — Florida Medical Cannabis Patients Surprised by Email Blast

Florida boasts more than 700,000 medical cannabis patients, and GOP Governor Ron DeSantis, who is currently opposing a proposal to legalize recreational cannabis, wants to highlight his achievements to this targeted group. Recently, Florida’s Health Department sent out an email to medical-cannabis patients, praising DeSantis for signing the state’s budget. The email also promoted a cancer research initiative by First Lady Casey DeSantis and highlighted various health issues addressed in the budget, including syphilis, HIV and hepatitis. However, the email did not mention medical cannabis, which has raised concerns among advocates and patients who argue that the administration misused the…

Continue Reading

MondayJul 01, 2024 10:00 am

DEA’s Rescheduling of Marijuana Could Be Delayed Beyond November Polls

Some experts believe that legislators that opposing the reclassification of marijuana under Schedule 3 may call for public hearings that will delay the U.S. Drug Enforcement Administration’s (DEA) final rule past the election. Some claim that this is the goal — to prevent President Joe Biden from boosting his appeal to younger voters. The 60-day public comment period on marijuana rescheduling, which shall inform the DEA’s decision, is set to lapse on July 20, 2024. Thirty days after this period ends, the DEA is expected to decide on whether to move marijuana from its Schedule I classification. The decision will…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

CannabisNewsWire

1108 Lavaca St
Suite 110-CNW
Austin, TX 78701
(512) 354-7000

Copyright © . CannabisNewsWire® / 1108 Lavaca St Suite 110-IBN Austin, TX 78701 (512) 354-7000 / Disclaimers